Breast Cancer Trial Results
- Heart Problems From Trastuzumab (Herceptin®) Do Not Increase in the Short Term
(Posted: 06/25/2007, Updated: 06/22/2010) - Women with breast cancer who take the drug trastuzumab (Herceptin®) are at risk of heart problems during treatment. Now a study has shown that the incidence of such problems does not increase in the short term, though the long-term effects remain unknown, according to findings presented at the 2007 ASCO meeting in Chicago.
- Some Older Women Can Forgo Radiation after Breast Cancer Surgery
(Posted: 06/22/2010) - Women 70 years of age or older with early-stage breast cancer did not benefit from the addition of radiation therapy to breast-conserving surgery and tamoxifen, according to results of a phase III randomized study presented in advance of the 2010 American Society of Clinical Oncology annual meeting.
- Shorter Course of Radiation Effective and Safe for Some Women with Early-stage Breast Cancer
(Posted: 03/15/2010) - Giving radiation therapy in fewer but larger doses may be an alternative to standard radiation therapy for some women with early-stage breast cancer, according to a study published in the February 11, 2010, New England Journal of Medicine.
- Acupuncture Reduces Joint Pain in Some Women with Breast Cancer
(Posted: 02/03/2010) - In a small randomized clinical trial, breast cancer patients experiencing joint pain and stiffness from aromatase inhibitor (AI) treatment reported an improvement in pain from acupuncture.
- Home Care Nursing Improves Cancer Symptom Management
(Posted: 12/16/2009) - Home care nursing (HCN) improves the management of symptoms in breast and colorectal cancer patients who take the oral chemotherapy drug capecitabine, according to a study published online November 16, 2009, in the Journal of Clinical Oncology.